Stakeholder Plan November 2017. 6.1.2.1 Advertisement(s) and Press Release(s) April 2018
Stakeholder Plan November 2017 Sample Clauses
Related to Stakeholder Plan November 2017
November 2016 Real GDP published for calendar 2015;
November 2020 Section 1 The objectives, targets, timeframe and other matters relating to official controls and other official activities which the Authority has specified to the Official Agency.
December 2016 Unless differently stated in forthcoming revisions of the current Voluntary Agreement, the following reports shall be established by 30 April every year covering products placed on the market during the previous full calendar year, e.g. by 30 April 2018 for products placed on the market between 1 January 2017 and 31 December 2017. Within two weeks following the end of a reporting period, the Independent Inspector shall send a request to the Signatories to file their Reports. These shall be submitted no later than two months and two weeks after the end of the reporting period. The Reports shall be compiled by the Independent Inspector into a draft annual progress report (the “Annual Progress Report”) that will be submitted to the European Commission and the Signatories by the 12 April of the calendar year following the end of the reporting period for the purpose of checking inconsistencies and quality. The Independent Inspector will submit the Final Annual Progress Report to the Steering Committee no later than 30 April of the calendar year following the end of the reporting period. This Annual Progress Report will only show anonymous results. Signatories will not be named although individual achievements shall be disclosed (company A, company B, etc.). In case a company is found to be non-compliant, the Annual Progress Report shall provide the identity of the Signatory and detail the reasons for such non-compliance. The Independent Inspector shall be responsible for ensuring that confidentiality of the Signatory’s identity and any data or information provided to it under or in relation to this agreement is maintained. This shall include entering into a non-disclosure agreement with each Signatory if requested by the Signatory.
December 2020 The funds of the 11th EDF, and in the case of the Investment Facility the funds stemming from reflows, shall no longer be committed beyond 31 December 2020 unless the Council acting unanimously on a proposal of the Commission decides otherwise. However, the funds subscribed by the Member States under the 9th, 10th and 11th EDFs to finance the Investment Facility shall remain available after 31 December 2020 for disbursement, until a date to be laid down in the Financial Regulation referred to in Article 10(2).
Educator Plans: Developing Educator Plan A) The Developing Educator Plan is for all Educators without PTS, and, at the discretion of the Evaluator, Educators with PTS in new assignments.
Using Student feedback in Educator Evaluation ESE will provide model contract language, direction and guidance on using student feedback in Educator Evaluation by June 30, 2013. Upon receiving this model contract language, direction and guidance, the parties agree to bargain with respect to this matter.
Educator Plans: Directed Growth Plan A) A Directed Growth Plan is for those Educators with PTS whose overall rating is needs improvement.
Local Union Business Leave The Hospital agrees to grant leaves of absence without pay to local bargaining unit members for the purpose of attending Union seminars and/or attending to Union business. The cumulative total leave of absence will be determined locally, but shall not exceed forty (40) days per year per hospital. The amount of notice required and the number of employees who may be absent at any one time and from any one area shall be determined locally and will be set out in the Local Provisions Appendix.
CFR Ch I (4–1–11 Edition)
372/2011 Sb o zdravotních službách a podmínkách jejich poskytování (zákon o zdravotních službách), pojištěno pro případ odpovědnosti za škodu způsobenou v souvislosti s poskytováním zdravotních služeb a že si je vědomo své povinnosti zajistit trvání tohoto pojištění po celou dobu poskytování zdravotních služeb. Příslušná pojistná smlouva je uzavřena v rozsahu požadovaném právními předpisy a neobsahuje pojištění odpovědnosti za škodu způsobenou při provádění klinického hodnocení nebo v souvislosti s ním ani nezajišťuje odškodnění v případě smrti subjektu hodnocení nebo v případě škody vzniklé na zdraví subjektu hodnocení v důsledku provádění klinického hodnocení.
